Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Audard

Showing results (71-80 of 181) with videos related to

Pageof 19
Sort By:
Kidney International|January 18, 2013
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change diseaseHelene Munyentwali, Khedidja Bouachi, Vincent Audard, et al.
Journal of Autoimmunity|October 24, 2017
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic SyndromeAhmed Boumediene, Pauline Vachin, Kelhia Sendeyo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2008
Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrumVincent Audard, Benoit Georges, Philippe Vanhille, et al.
Scientific Reports|July 27, 2025
Podocyte dysfunction driven by heme in sickle-cell nephropathyChloé Ben Ali, Antoine Morel, Marion Morvan, et al.
Orphanet Journal of Rare Diseases|May 1, 2014
First evidence of subclinical renal tubular injury during sickle-cell crisisVincent Audard, Stéphane Moutereau, Gaetana Vandemelebrouck, et al.
The American Journal of Pathology|April 18, 2012
c-mip down-regulates NF-κB activity and promotes apoptosis in podocytesVirginie Ory, Qingfeng Fan, Nabila Hamdaoui, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 5, 2021
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort studyAntoine Morel, Yaniss Ouamri, Florence Canouï-Poitrine, et al.
Transplantation|February 14, 2007
The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejectionPhilippe Grimbert, Hicham Mansour, D Desvaux, et al.
Medicine|January 16, 2010
Glomerular lesions in patients with sickle cell diseaseGwenola Maigne, Sophie Ferlicot, Frederic Galacteros, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2016
C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort studyAnissa Moktefi, Juliette Parisot, Dominique Desvaux, et al.
Pageof 19

Showing results (71-80 of 181) with videos related to

Sort By:
Pageof 19
Kidney International|January 18, 2013
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change diseaseHelene Munyentwali, Khedidja Bouachi, Vincent Audard, et al.
Journal of Autoimmunity|October 24, 2017
NEPHRUTIX: A randomized, double-blind, placebo vs Rituximab-controlled trial assessing T-cell subset changes in Minimal Change Nephrotic SyndromeAhmed Boumediene, Pauline Vachin, Kelhia Sendeyo, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2008
Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrumVincent Audard, Benoit Georges, Philippe Vanhille, et al.
Scientific Reports|July 27, 2025
Podocyte dysfunction driven by heme in sickle-cell nephropathyChloé Ben Ali, Antoine Morel, Marion Morvan, et al.
Orphanet Journal of Rare Diseases|May 1, 2014
First evidence of subclinical renal tubular injury during sickle-cell crisisVincent Audard, Stéphane Moutereau, Gaetana Vandemelebrouck, et al.
The American Journal of Pathology|April 18, 2012
c-mip down-regulates NF-κB activity and promotes apoptosis in podocytesVirginie Ory, Qingfeng Fan, Nabila Hamdaoui, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 5, 2021
Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort studyAntoine Morel, Yaniss Ouamri, Florence Canouï-Poitrine, et al.
Transplantation|February 14, 2007
The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejectionPhilippe Grimbert, Hicham Mansour, D Desvaux, et al.
Medicine|January 16, 2010
Glomerular lesions in patients with sickle cell diseaseGwenola Maigne, Sophie Ferlicot, Frederic Galacteros, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 20, 2016
C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort studyAnissa Moktefi, Juliette Parisot, Dominique Desvaux, et al.
Pageof 19